These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32545609)

  • 1. Detection of Parkinson's Disease from 3T T1 Weighted MRI Scans Using 3D Convolutional Neural Network.
    Chakraborty S; Aich S; Kim HC
    Diagnostics (Basel); 2020 Jun; 10(6):. PubMed ID: 32545609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D Textural, Morphological and Statistical Analysis of Voxel of Interests in 3T MRI Scans for the Detection of Parkinson's Disease Using Artificial Neural Networks.
    Chakraborty S; Aich S; Kim HC
    Healthcare (Basel); 2020 Feb; 8(1):. PubMed ID: 32046073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fully automated approach involving neuroimaging and deep learning for Parkinson's disease detection and severity prediction.
    Erdaş ÇB; Sümer E
    PeerJ Comput Sci; 2023; 9():e1485. PubMed ID: 37547409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson's disease using convolutional neural network.
    Gaurav R; Valabrègue R; Yahia-Chérif L; Mangone G; Narayanan S; Arnulf I; Vidailhet M; Corvol JC; Lehéricy S
    Neuroimage Clin; 2022; 36():103250. PubMed ID: 36451356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Ensemble of CNN Models for Parkinson's Disease Detection Using DaTscan Images.
    Kurmi A; Biswas S; Sen S; Sinitca A; Kaplun D; Sarkar R
    Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of Parkinson's Disease in Patch-Based MRI of Substantia Nigra.
    Hussain SS; Degang X; Shah PM; Islam SU; Alam M; Khan IA; Awwad FA; Ismail EAA
    Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease.
    Hatano T; Okuzumi A; Kamagata K; Daida K; Taniguchi D; Hori M; Yoshino H; Aoki S; Hattori N
    J Neural Transm (Vienna); 2017 Apr; 124(4):407-415. PubMed ID: 28160151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.
    Schwarz ST; Rittman T; Gontu V; Morgan PS; Bajaj N; Auer DP
    Mov Disord; 2011 Aug; 26(9):1633-8. PubMed ID: 21491489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease.
    Lehéricy S; Bardinet E; Poupon C; Vidailhet M; François C
    Mov Disord; 2014 Nov; 29(13):1574-81. PubMed ID: 25308960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts.
    Hwang KS; Langley J; Tripathi R; Hu XP; Huddleston DE
    PLoS One; 2023; 18(4):e0282684. PubMed ID: 37053195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Anatomical and Diffusion MRI for detecting Parkinson's Disease using Deep Convolutional Neural Network.
    Chattopadhyay T; Singh A; Laltoo E; Boyle CP; Owens-Walton C; Chen YL; Cook P; McMillan C; Tsai CC; Wang JJ; Wu YR; van der Werf Y; Thompson PM
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-6. PubMed ID: 38083460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Explainable classification of Parkinson's disease using deep learning trained on a large multi-center database of T1-weighted MRI datasets.
    Camacho M; Wilms M; Mouches P; Almgren H; Souza R; Camicioli R; Ismail Z; Monchi O; Forkert ND
    Neuroimage Clin; 2023; 38():103405. PubMed ID: 37079936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Anatomical and Diffusion MRI for detecting Parkinson's Disease using Deep Convolutional Neural Network.
    Chattopadhyay T; Singh A; Laltoo E; Boyle CP; Owens-Walton C; Chen YL; Cook P; McMillan C; Tsai CC; Wang JJ; Wu YR; van der Werf Y; Thompson PM
    bioRxiv; 2023 May; ():. PubMed ID: 37205416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson's Disease.
    Eyer GC; Di Santo S; Hewer E; Andereggen L; Seiler S; Widmer HR
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the deep convolutional neural network as an aid to interpreting brain [
    Piccardo A; Cappuccio R; Bottoni G; Cecchin D; Mazzella L; Cirone A; Righi S; Ugolini M; Bianchi P; Bertolaccini P; Lorenzini E; Massollo M; Castaldi A; Fiz F; Strada L; Cistaro A; Del Sette M
    Eur Radiol; 2021 Sep; 31(9):7003-7011. PubMed ID: 33686474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive markers for Parkinson's disease using deep neural nets on neuromelanin sensitive MRI.
    Shinde S; Prasad S; Saboo Y; Kaushick R; Saini J; Pal PK; Ingalhalikar M
    Neuroimage Clin; 2019; 22():101748. PubMed ID: 30870733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
    Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
    Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson's disease.
    Ogisu K; Kudo K; Sasaki M; Sakushima K; Yabe I; Sasaki H; Terae S; Nakanishi M; Shirato H
    Neuroradiology; 2013 Jun; 55(6):719-24. PubMed ID: 23525598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary attempt to visualize nigrosome 1 in the substantia nigra for Parkinson's disease at 3T: An efficient susceptibility map-weighted imaging (SMWI) with quantitative susceptibility mapping using deep neural network (QSMnet).
    Jo M; Oh SH
    Med Phys; 2020 Mar; 47(3):1151-1160. PubMed ID: 31883389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.